| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9866 | 
      | Human Intestinal Absorption | HIA+ | 0.9894 | 
      | Caco-2 Permeability | Caco2+ | 0.7670 | 
      | P-glycoprotein Substrate | Substrate | 0.7040 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.6980 | 
                                                     | Inhibitor | 0.6302 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.5960 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5070 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7990 | 
      | CYP450 2D6 Substrate | Substrate | 0.6679 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5000 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8586 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9102 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7651 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6685 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9849 | 
                                                                    | Inhibitor | 0.8210 | 
      | AMES Toxicity | Non AMES toxic | 0.7543 | 
      | Carcinogens | Non-carcinogens | 0.8762 | 
      | Fish Toxicity | High FHMT | 0.8242 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7604 | 
      | Honey Bee Toxicity | Low HBT | 0.6588 | 
      | Biodegradation | Not ready biodegradable | 0.9951 | 
      | Acute Oral Toxicity | II | 0.6901 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6279 |